-
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group, 2025, (E-pub ahead of print) In: The Lancet Infectious Diseases.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications